VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy	Cancer of Urinary Tract, Embolism and Thrombosis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Thromboembolism, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, cardiovascular disorder, neoplasm, urinary system disorder, vascular disorder, venous thromboembolism	Recruiting	Phase 2 / Phase 3	2025-07-10		NCT05920343

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Institutes of Health Research (CIHR)	339
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network	4
Kidney Cancer Research Network of Canada	1
Ottawa Hospital Research Institute	121

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ottawa Hospital Research Institute	Ottawa	Canada	46